Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 1
1997 1
1998 1
1999 1
2000 3
2001 1
2002 7
2003 10
2004 14
2005 6
2006 10
2007 19
2008 21
2009 11
2010 22
2011 28
2012 23
2013 40
2014 44
2015 39
2016 22
2017 17
2018 24
2019 19
2020 10
2021 22
2022 9
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

373 results

Results by year

Filters applied: . Clear all
Page 1
11C-choline PET/CT and PSA kinetics.
Castellucci P, Picchio M. Castellucci P, et al. Eur J Nucl Med Mol Imaging. 2013 Jul;40 Suppl 1:S36-40. doi: 10.1007/s00259-013-2377-z. Epub 2013 Apr 12. Eur J Nucl Med Mol Imaging. 2013. PMID: 23579864 Review.
PET Radiotracers in Atherosclerosis: A Review.
Blanchard I, Vootukuru N, Bhattaru A, Patil S, Rojulpote C. Blanchard I, et al. Curr Probl Cardiol. 2023 Nov;48(11):101925. doi: 10.1016/j.cpcardiol.2023.101925. Epub 2023 Jun 30. Curr Probl Cardiol. 2023. PMID: 37392979 Review.
Gallium-68 DOTA-0-Tyr3-Octreotate (68Ga-DOTATATE) PET has also shown potential in identifying vulnerable atherosclerotic plaques with high somatostatin receptor expression. Finally, 11-carbon (11C)-choline and 18F-fluoromethylcholine (FMCH) tracers may identify high …
Gallium-68 DOTA-0-Tyr3-Octreotate (68Ga-DOTATATE) PET has also shown potential in identifying vulnerable atherosclerotic plaques with high s …
Choline PET/CT in Multiple Myeloma.
Mesguich C, Hulin C, Lascaux A, Bordenave L, Marit G, Hindié E. Mesguich C, et al. Cancers (Basel). 2020 May 28;12(6):1394. doi: 10.3390/cancers12061394. Cancers (Basel). 2020. PMID: 32481661 Free PMC article. Review.
Trends in oncologic hybrid imaging.
Wibmer AG, Hricak H, Ulaner GA, Weber W. Wibmer AG, et al. Eur J Hybrid Imaging. 2018;2(1):1. doi: 10.1186/s41824-017-0019-6. Epub 2018 Jan 19. Eur J Hybrid Imaging. 2018. PMID: 29782605 Free PMC article. Review.
Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer.
Kitajima K, Yamamoto S, Odawara S, Kobayashi K, Fujiwara M, Kamikonya N, Fukushima K, Nakanishi Y, Hashimoto T, Yamada Y, Suzuki T, Kanematsu A, Nojima M, Yamakado K. Kitajima K, et al. Acta Med Okayama. 2018 Jun;72(3):289-296. doi: 10.18926/AMO/56075. Acta Med Okayama. 2018. PMID: 29926007 Free article.
We compared 11C-choline and FDG PET/CT scan findings for the staging and restaging of prostate cancer. Twenty Japanese prostate cancer patients underwent 11C-choline and FDG PET/CT before (n=5) or after (n=15) treatment. ...
We compared 11C-choline and FDG PET/CT scan findings for the staging and restaging of prostate cancer. Twenty Japanese prostat …
Accuracy of 11C-choline positron emission tomography in differentiating glioma recurrence from radiation necrosis: A systematic review and meta-analysis.
Gao L, Xu W, Li T, Zheng J, Chen G. Gao L, et al. Medicine (Baltimore). 2018 Jul;97(29):e11556. doi: 10.1097/MD.0000000000011556. Medicine (Baltimore). 2018. PMID: 30024551 Free PMC article. Review.
We therefore assume it is of need to exert a meta-analysis to evaluate the diagnostic accuracy of 11C-choline positron emission tomography (PET), to achieve this goal. ...Fixed-effects models were used. Summary diagnostic accuracy of 11C-choline PET wa …
We therefore assume it is of need to exert a meta-analysis to evaluate the diagnostic accuracy of 11C-choline positron emissio …
PET imaging in renal cancer.
Lindenberg L, Mena E, Choyke PL, Bouchelouche K. Lindenberg L, et al. Curr Opin Oncol. 2019 May;31(3):216-221. doi: 10.1097/CCO.0000000000000518. Curr Opin Oncol. 2019. PMID: 30747736 Free PMC article. Review.
Current research on PET imaging agents in RCC including 89Zr bevacizumab, 89Zr geruntuximab, 18F fluoro-L-thymidine (FLT), prostate-specific membrane antigen (PSMA), 11C choline, 18F sodium fluoride (NaF), and18F fluorodeoxyglucose (FDG) have shown some interesting …
Current research on PET imaging agents in RCC including 89Zr bevacizumab, 89Zr geruntuximab, 18F fluoro-L-thymidine (FLT), prostate-specific …
373 results